Chromatin remodeling with combined FACT and BET inhibition disrupts oncogenic transcription in Diffuse Midline Glioma
Holly Holliday, Aaminah Khan, Anahid Ehteda, Hieu Nguyen, Samuel E. Ross, Nisitha Jayatilleke, Anjana Gopalakrishnan, Eyden Wang, Yolanda Colino‐Sanguino, Daisy Kavanagh, Xinyi Guo, Jie Liu, David Lawrence, Claire Xin Sun, Rebecca J. Lehmann, , David Simon Ziegler
This study shows that combining FACT and BET inhibition disrupts oncogenic transcription and extends survival in Diffuse Midline Glioma models.
Science Translational Medicine · Jan 14, 2026Peer-reviewedCancer Biology